Zobrazeno 1 - 10
of 47
pro vyhledávání: '"Uwe Klaus, Zettl"'
Autor:
Janina Meißner, Niklas Frahm, Michael Hecker, Silvan Elias Langhorst, Pegah Mashhadiakbar, Barbara Streckenbach, Katja Burian, Julia Baldt, Felicita Heidler, Jörg Richter, Uwe Klaus Zettl
Publikováno v:
Therapeutic Advances in Neurological Disorders, Vol 17 (2024)
Background: The modifiable risk factor exerting the most substantial influence on the development and disease course of multiple sclerosis (MS) is cigarette smoking. Furthermore, smoking is associated with a higher risk of suffering from one or more
Externí odkaz:
https://doaj.org/article/3ddc7082b198487295d9ac6ebf8978d5
Autor:
Katja Burian, Felicita Heidler, Niklas Frahm, Michael Hecker, Silvan Elias Langhorst, Pegah Mashhadiakbar, Barbara Streckenbach, Julia Baldt, Janina Meißner, Jörg Richter, Uwe Klaus Zettl
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-13 (2024)
Abstract The recent SARS-CoV-2 pandemic and the vaccination campaign posed a challenge to patients with autoimmune disease, such as multiple sclerosis (MS). We aimed for investigating whether psychological/sociodemographic/clinical characteristics of
Externí odkaz:
https://doaj.org/article/0243244606ff4835a2f34a8992d78efe
Publikováno v:
The Lancet Regional Health. Europe, Vol 42, Iss , Pp 100950- (2024)
Externí odkaz:
https://doaj.org/article/a4e4d1d17d4147dc8373002fa3c7a167
Autor:
Michael Hecker, Brit Fitzner, Nina Boxberger, Elena Putscher, Robby Engelmann, Wendy Bergmann, Michael Müller, Isis Ludwig-Portugall, Margit Schwartz, Stefanie Meister, Ales Dudesek, Alexander Winkelmann, Dirk Koczan, Uwe Klaus Zettl
Publikováno v:
Journal of Neuroinflammation, Vol 20, Iss 1, Pp 1-18 (2023)
Abstract Background Multiple sclerosis (MS) is a chronic, inflammatory and neurodegenerative disease that leads to irreversible damage to the brain and spinal cord. The goal of so-called "immune reconstitution therapies" (IRTs) is to achieve long-ter
Externí odkaz:
https://doaj.org/article/f17f465a1e9f4f1ab39b134ac143e068
Autor:
Felicita Heidler, Julia Baldt, Niklas Frahm, Silvan Elias Langhorst, Pegah Mashhadiakbar, Barbara Streckenbach, Katja Burian, Uwe Klaus Zettl, Jörg Richter
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-10 (2022)
Abstract Vaccination is a key strategy for controlling the SARS-CoV-2 pandemic. Acceptance of SARS-CoV-2 vaccines by chronically ill patients, such as multiple sclerosis (MS) patients, plays an important role in prevention of complicated disease cour
Externí odkaz:
https://doaj.org/article/645b8678adf148479a9816cddc500b7b
Publikováno v:
Pharmaceutics, Vol 16, Iss 1, p 3 (2023)
Patients with multiple sclerosis (MS) often take multiple drugs at the same time to modify the course of disease, alleviate neurological symptoms and manage co-existing conditions. A major consequence for a patient taking different medications is a h
Externí odkaz:
https://doaj.org/article/05f2667925264b8eac8149d5ab00069a
Autor:
Marie-Celine Haker, Niklas Frahm, Michael Hecker, Silvan Elias Langhorst, Pegah Mashhadiakbar, Jane Louisa Debus, Barbara Streckenbach, Julia Baldt, Felicita Heidler, Uwe Klaus Zettl
Publikováno v:
Therapeutic Advances in Drug Safety, Vol 14 (2023)
Background: Although effective contraception is strongly recommended during the therapy of women with multiple sclerosis (MS) with some immunomodulatory drugs, unplanned pregnancies still occur. Adequate medication management is essential to avoid fo
Externí odkaz:
https://doaj.org/article/07c34c4711ef44029636bb6a1a608feb
Autor:
Elena Putscher, Michael Hecker, Brit Fitzner, Nina Boxberger, Margit Schwartz, Dirk Koczan, Peter Lorenz, Uwe Klaus Zettl
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
BackgroundMultiple sclerosis (MS) is a chronic immune-mediated disease of the central nervous system to which a genetic predisposition contributes. Over 200 genetic regions have been associated with increased disease risk, but the disease-causing var
Externí odkaz:
https://doaj.org/article/33ac74953c38475e8339f0e7878270cc
Autor:
Michael Hecker, Niklas Frahm, Paula Bachmann, Jane Louisa Debus, Marie-Celine Haker, Pegah Mashhadiakbar, Silvan Elias Langhorst, Julia Baldt, Barbara Streckenbach, Felicita Heidler, Uwe Klaus Zettl
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
Background: Patients with multiple sclerosis (MS) often undergo complex treatment regimens, resulting in an increased risk of polypharmacy and potential drug-drug interactions (pDDIs). Drug interaction databases are useful for identifying pDDIs to su
Externí odkaz:
https://doaj.org/article/90ce57165a814843921a55a9b6f19721
Autor:
Jane Louisa Debus, Paula Bachmann, Niklas Frahm, Pegah Mashhadiakbar, Silvan Elias Langhorst, Barbara Streckenbach, Julia Baldt, Felicita Heidler, Michael Hecker, Uwe Klaus Zettl
Publikováno v:
Therapeutic Advances in Chronic Disease, Vol 13 (2022)
Background: Multiple sclerosis (MS) is the most common immune-mediated demyelinating disease in younger adults. Patients with MS (PwMS) are vulnerable to the presence of potential drug–drug interactions (pDDIs) and potential drug–food interaction
Externí odkaz:
https://doaj.org/article/7ffed6baa81046d5b6ffffbd26dad43b